These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19499569)

  • 1. Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo.
    Zhang S; Sagawa K; Arnold RD; Tseng E; Wang X; Morris ME
    J Pharm Sci; 2010 Jan; 99(1):430-41. PubMed ID: 19499569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport.
    Zhang S; Morris ME
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1258-67. PubMed ID: 12604704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved effectiveness of biochanin A as a P-gp inhibitor in solid dispersion.
    Han HK; Lee HK
    Pharmazie; 2011 Sep; 66(9):710-5. PubMed ID: 22026129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the isoflavonoid biochanin A on the transport of mitoxantrone in vitro and in vivo.
    An G; Morris ME
    Biopharm Drug Dispos; 2010 Jul; 31(5-6):340-50. PubMed ID: 20535833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of P-glycoprotein by natural products in human breast cancer cells.
    Chung SY; Sung MK; Kim NH; Jang JO; Go EJ; Lee HJ
    Arch Pharm Res; 2005 Jul; 28(7):823-8. PubMed ID: 16114498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells.
    Nguyen H; Zhang S; Morris ME
    J Pharm Sci; 2003 Feb; 92(2):250-7. PubMed ID: 12532374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Class of Safe, Potent, and Specific P-gp Modulator: Flavonoid Dimer FD18 Reverses P-gp-Mediated Multidrug Resistance in Human Breast Xenograft in Vivo.
    Yan CS; Wong IL; Chan KF; Kan JW; Chong TC; Law MC; Zhao Y; Chan SW; Chan TH; Chow LM
    Mol Pharm; 2015 Oct; 12(10):3507-17. PubMed ID: 26291333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of coumarin derivative-mediated inhibition of P-glycoprotein on oral bioavailability and therapeutic efficacy of paclitaxel.
    Lee K; Chae SW; Xia Y; Kim NH; Kim HJ; Rhie S; Lee HJ
    Eur J Pharmacol; 2014 Jan; 723():381-8. PubMed ID: 24252806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A.
    Peng SX; Ritchie DM; Cousineau M; Danser E; Dewire R; Floden J
    J Pharm Sci; 2006 Sep; 95(9):1984-93. PubMed ID: 16850393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of P-glycoprotein-mediated daunomycin transport in rat liver canalicular membrane vesicles.
    Kwon Y; Kamath AV; Morris ME
    J Pharm Sci; 1996 Sep; 85(9):935-9. PubMed ID: 8877882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats.
    Lee CK; Choi JS
    Pharmacology; 2010; 85(6):350-6. PubMed ID: 20523105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.
    Li X; Choi JS
    Int J Pharm; 2007 Jun; 337(1-2):188-93. PubMed ID: 17267149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor effects of the citrus flavonoids naringin, naringenin and quercetin, on the pharmacokinetics of doxorubicin in rats.
    Park HS; Oh JH; Lee Jh; Lee YJ
    Pharmazie; 2011 Jun; 66(6):424-9. PubMed ID: 21699081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats.
    Singh SP; Wahajuddin ; Raju KS; Ali MM; Kohli K; Jain GK
    Phytother Res; 2012 Feb; 26(2):303-7. PubMed ID: 22131128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells.
    Zhang S; Morris ME
    Pharm Res; 2003 Aug; 20(8):1184-91. PubMed ID: 12948016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
    Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of myricetin on the bioavailability of carvedilol in rats.
    Lee W; Woo ER; Choi JS
    Pharm Biol; 2012 Apr; 50(4):516-22. PubMed ID: 22132944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin.
    Cho YA; Lee W; Choi JS
    Pharmazie; 2012 Feb; 67(2):124-30. PubMed ID: 22512082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of enaminones on the transport and oral bioavailability of P-glycoprotein substrate therapeutic agents.
    Salama NN; Scott KR; Eddington ND
    Int J Pharm; 2004 Apr; 273(1-2):135-47. PubMed ID: 15010138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
    Choi BC; Choi JS; Han HK
    Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.